SUMATRIPTAN; NAPROXEN SODIUM (SUMATRIPTAN; NAPROXEN SODIUM) — FDA Approval ANDA090753 (PAR PHARM)
SUMATRIPTAN; NAPROXEN SODIUM (SUMATRIPTAN; NAPROXEN SODIUM) — FDA Approval ANDA090753 (PAR PHARM) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SUMATRIPTAN; NAPROXEN SODIUM; Active ingredients: SUMATRIPTAN; NAPROXEN SODIUM; Application number: ANDA090753.
| Brand name | SUMATRIPTAN; NAPROXEN SODIUM |
|---|---|
| Active ingredients | SUMATRIPTAN; NAPROXEN SODIUM |
| Application number | ANDA090753 |
| Sponsor | PAR PHARM |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | None (Tentative Approval) |
| Products in application | 1 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →